CTRI/2023/11/059542尚未招募3 期
Mycophenolate Mofetil for induction and as steroid sparing agent in the treatment of Idiopathic Inflammatory Myositis-An open Labeled study - NI
DrFathima Nilofar0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients aged more than 16 years of age diagnosed with Idiopathic Inflammatory Myositis.
- •Patients were classified in to Primary adult Polymyositis, Primary adult Dermatomyositis and Inclusion Body Myositis.
排除标准
- •Patients below 16 years of age.
- •patients with Endocrine disorders like thyroid and diabetes mellitus.
- •patients with inherited muscle dystrophy.
- •patients with paraneoplastic myositis and overlap myositis.
- •patients with drug induced myositis.
研究者
相似试验
已完成
不适用
Mycophenolate mofetil treatment for steroid resistant nephrotic syndromesteroid resistant nephrotic syndromeJPRN-UMIN000002740Kumamoto University, Department of Pediatrics1
已完成
3 期
Evaluation of mycophenolate mofetil and prednisolone effect as initial treatment on idiopathic membranous nephropathyChronic nephritic syndrome.Chronic nephritic syndromeIRCT20180128038539N1Ahvaz University of Medical Sciences30
已完成
3 期
Micophenolate Mofetil Versus Azathioprine in MyocarditisLymphocytic Myocarditis (Disorder)CardiomyopathiesHeart FailureDilated CardiomyopathySudden Cardiac DeathNCT05237323I.M. Sechenov First Moscow State Medical University50
进行中（未招募）
4 期
An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity PneumonitisHypersensitivity PneumonitisNCT05626387Post Graduate Institute of Medical Education and Research, Chandigarh144
进行中（未招募）
不适用
Intervention with mycophenolate mofetil and daclizumab in patients with recently diagnosed type 1 diabetes mellitus - MMF/DZB StudieType 1 diabetes, recently diagnosedEUCTR2005-000904-15-DEGeorge Washington University Biostatistics Center180